Compass Therapeutics Inc
CMPX
Get informed when a big investor buys or sells
+ FollowMarket Cap$432.21M
Close$
$0.13
94.6% downside
Current Fair Value
94.6% downsideOvervalued by 94.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $432.21 Million |
|---|---|
| Enterprise Value | $406.39 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.42 |
| Beta | 0.82 |
| Outstanding Shares | 186,798,000 |
Return
| Return on Equity | -44.23% |
|---|---|
| Return on Assets | -38.62% |
| Return on Invested Capital | -34.31% |
Valuation & Multiples
| P/E Ratio | -5.78 |
|---|---|
| PEG | -21.8 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -6.81 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$-600,000
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$229,250
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0570▲ 5.70% |
|---|---|
| Total Calls | 3,312,300▲ Infinity% |
| Total Puts | 188,900▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.94%▲ 4.14% |
|---|---|
| Total Invested | $919.10M▲ 4.27% |
| Investors Holding | 209▲ 36.00% |
ESG Score
No data